Brain Resource grabs $10M, hunts for markers

Australia-based Brain Resource has set up a U.S. beachhead in San Francisco and hauled in $10 million to advance its web-based brain products. While the company is established providing software for the employer and consumer markets, it's currently working on a large study to help find treatment prediction markers for depression and ADHD meds. Och-Ziff Capital Management provided the fresh round of financing for the Australian firm. Article

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.